对抗体与药物合物的抵抗机制
Rita Khoury1, Khalil Saleh1, Nadine Khalife2
1International Department, Gustave Roussy Cancer Campus, 94800 Villejuif, France.
International journal of molecular sciences
|June 10, 2023
概括
抗体-药物合物 (ADC) 在癌症治疗中表现有前途,但耐药性可能会限制它们的有效性. 诸如双特异性ADC和组合疗法等策略正在探索以克服这些挑战.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 药理学 药理学是指药理学的学科.
背景情况:
- 癌症治疗已经通过单克隆抗体和T细胞疗法等免疫疗法取得了进展.
- 抗体-药物合物 (ADC) 代表了癌症治疗的重大进步,有几种已被批准用于血液和固体瘤.
- 已批准的ADC包括特祖马布埃姆坦辛 (T-DM1),特祖马布德鲁克斯泰肯 (T-DXd),萨基图祖马布戈维特肯 (SG) 和恩福图祖马布维多丁 (EV).
研究的目的:
- 审查支持批准关键ADCs (T-DM1,T-DXd,SG,EV) 的临床数据.
- 讨论ADC治疗耐药性背后的机制.
- 探索克服ADC耐药性的策略.
主要方法:
- 对已批准的ADC进行临床试验数据的审查.
- 关于ADC抗性机制的科学文献分析.
- 探索新的治疗策略,包括双特异性ADC和组合疗法.
主要成果:
- 像T-DM1,T-DXd,SG和EV这样的ADC已经在治疗转移性乳腺癌和泌尿腺癌方面表现出有效性.
- 对ADCs的耐药性可能来自与抗原相关的问题,受损的内化和溶酶体功能障碍.
- 新兴的策略旨在通过克服抵抗机制来提高ADC的疗效.
结论:
- ADCs已经彻底改变了癌症治疗,但耐药性仍然是一个重大的临床挑战.
- 了解耐药机制对于制定有效的治疗策略至关重要.
- 双特异性ADC和组合疗法有望改善当前ADC耐药患者的治疗结果.
关键词:
抗体与药物结合物的结合物.恩福图马布 (enfortumab) 是一种可见的药物.链接器是一个链接器.一个单克隆抗体.实用载荷的有效载荷是什么萨基图祖马布 (Sacituzumab) govitecan可以使用.特拉斯图祖马布可以脱.特拉斯图祖马布 (Trastuzumab) 是一种乳素.更多相关视频
11:58Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
Published on: March 8, 2018
7.7K
09:39Targeted Antibody Blocking by a Dual-Functional Conjugate of Antigenic Peptide and Fc-III Mimetics DCAF
Published on: September 17, 2019
6.9K
相关概念视频
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Antibody Actions
1.2K
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
1.2K
Development of Antibiotic Resistance
48
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
48
Protein-Drug Binding: Mechanism and Kinetics
658
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
658
Humoral Immune Responses
73.3K
Overview
73.3K
Factors Affecting Protein-Drug Binding: Drug Interactions
207
Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
207
